FDA Inspection
VitalantVitalant – FDA Inspection, Jun 19, 2019
Record Details
This FDA Inspection record concerns Vitalant, with an inspection on June 19, 2019, issued by the Center for Biologics Evaluation and Research, covering biologics.
View Company Profile
ID · a3002c8b-b3c5-4254-939b-d6a97c0ab620
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 1094101
- FDA center
- Biologics
- Project area
- Blood and Blood Products
- Outcome
- Form 483 issued
FDA Citations
1- 21 CFR 606.160(b)Required records
Full citation text and observation details available on the Dashboard.
Other FDA inspections of Vitalant
7| Date | Classification | Office | Project area |
|---|---|---|---|
| July 11, 2024 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| October 25, 2016 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| August 18, 2016 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| May 23, 2014 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| September 12, 2013 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
Other documents for Vitalant
- FDA Inspection 1231512 - 2024-07-11
- FDA Inspection 993571 - 2016-10-25
- FDA Inspection 984244 - 2016-08-18
- FDA Inspection 879849 - 2014-05-23
- FDA Inspection 848850 - 2013-09-12
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.